|
From presentation to paper: Gender disparities in oncological research. |
|
Willemieke P.M. Dijksterhuis |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Eisai; Pfizer |
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech |
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Merck Sharp & Dohme; Novartis; Roche/Genentech |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche |
|
|
Consulting or Advisory Role - Eisai (I); Nutricia; Nutricia (I) |
Speakers' Bureau - Ipsen (I); Merck Serono (I); Pfizer; Pfizer (I) |
Research Funding - Pfizer; Pfizer |
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Advanced Accelerator Applications (I); Bayer (I); Celgene (I); Ipsen; Ipsen (I); Mylan (I); NanoString Technologies; Novartis; Novartis (I); Pfizer (I) |
|
|
Research Funding - Celldex (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Carlos Alberto Gomez-Roca |
Honoraria - AstraZeneca; Bristol-Myers Squibb; Foundation Medicine |
Consulting or Advisory Role - Bristol-Myers Squibb |
Research Funding - Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pierre Fabre; Roche |
|
Hanneke W.M. Van Laarhoven |
Honoraria - Lilly/ImClone |
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Nordic Group |
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - AstraZeneca |